Home Tags Lecanemab

Tag: Lecanemab

Japan – “LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
Business

Japan – “LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom

Leslie Atkins -
0
Japan – “LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
Business

Japan – “LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China

Editor -
0
LEQEMBI(R) (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
Business

LEQEMBI(R) (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia

Leslie Atkins -
0
Japan – Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Business

Japan – Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Correspondent -
0
“LEQEMBI” (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico
Business

“LEQEMBI” (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico

Editor -
0
Japan – “LEQEMBI” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea
Business

Japan – “LEQEMBI” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea

Leslie Atkins -
0
Japan – Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain
Business

Japan – Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain

-
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates

-
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel

Editor -
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong

-
0
Japan – “LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea
Business

Japan – “LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea

-
0
Japan – Eisai’s Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint
Business

Japan – Eisai’s Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint

-
0
Get $10 by answering a Simple Survey. Click Here